British investment firm Permira announced that it is again considering the sale of the well-known footwear manufacturer Dr. Martens or organizing an initial public offering, as Permira’s strategy provides for some unloading of its business.
As part of this strategy, the company decided back in 2019 to get rid of the shoe brand. At the moment there are several potential buyers, but negotiations with them are still at the initial stage.
It is reported that the company does not intend to rush to a final decision, as it is still satisfied with the performance of the business.
Since 2014, when Permira acquired the footwear business for 380 million euros, it has opened a number of new stores around the world and expanded its e-commerce offerings.
In the 12 months to March 2020, when the COVID-19 outbreak began, Dr. Martens’ operating profit jumped 110% to £ 142.5 million.
